{
  "resourceType" : "CodeSystem",
  "id" : "kepi-antigen",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem kepi-antigen</b></p><a name=\"kepi-antigen\"> </a><a name=\"hckepi-antigen\"> </a><p>This  code system <code>https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">bcg<a name=\"kepi-antigen-bcg\"> </a></td><td>BCG</td><td>Bacille Calmette-Guerin vaccine, given at birth against tuberculosis.</td></tr><tr><td style=\"white-space:nowrap\">bopv<a name=\"kepi-antigen-bopv\"> </a></td><td>Bivalent oral poliovirus vaccine</td><td>Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">ipv<a name=\"kepi-antigen-ipv\"> </a></td><td>Inactivated poliovirus vaccine</td><td>Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them.</td></tr><tr><td style=\"white-space:nowrap\">penta<a name=\"kepi-antigen-penta\"> </a></td><td>DTP-HepB-Hib (pentavalent) vaccine</td><td>Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">pcv10<a name=\"kepi-antigen-pcv10\"> </a></td><td>Pneumococcal conjugate vaccine (PCV10)</td><td>Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks.</td></tr><tr><td style=\"white-space:nowrap\">rota<a name=\"kepi-antigen-rota\"> </a></td><td>Rotavirus vaccine</td><td>Oral rotavirus vaccine, given at 6 and 10 weeks.</td></tr><tr><td style=\"white-space:nowrap\">mr<a name=\"kepi-antigen-mr\"> </a></td><td>Measles-rubella vaccine</td><td>Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years.</td></tr><tr><td style=\"white-space:nowrap\">yf<a name=\"kepi-antigen-yf\"> </a></td><td>Yellow fever vaccine</td><td>Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone.</td></tr></table></div>"
  },
  "url" : "https://fhir.slade360.co.ke/fhir/CodeSystem/kepi-antigen",
  "version" : "0.1.0",
  "name" : "SGHIKEPIAntigenCodeSystem",
  "title" : "SGHI KEPI Antigen",
  "status" : "active",
  "date" : "2026-09-15T11:40:24+00:00",
  "publisher" : "Kathurima Kimathi",
  "contact" : [{
    "name" : "Kathurima Kimathi",
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.linkedin.com/in/kathurima-kimathi/"
    },
    {
      "system" : "email",
      "value" : "kathurimakimathi415@gmail.com"
    }]
  },
  {
    "name" : "Oscar John",
    "telecom" : [{
      "system" : "email",
      "value" : "oscarjohnotieno@gmail.com",
      "use" : "work"
    }]
  },
  {
    "name" : "Kennedy Omondi",
    "telecom" : [{
      "system" : "email",
      "value" : "kennankole@gmail.com",
      "use" : "work"
    }]
  }],
  "description" : "Antigens administered under the Kenya Expanded Programme on Immunisation, as recorded on the MOH 510 Immunisation Permanent Register. One concept per antigen: the dose within a series is carried separately on Immunization.protocolApplied.doseNumber, which is what keeps IPV distinct from bivalent OPV and separates the three pentavalent doses. Pending a mapping to CVX or the national antigen list.",
  "content" : "complete",
  "count" : 8,
  "concept" : [{
    "code" : "bcg",
    "display" : "BCG",
    "definition" : "Bacille Calmette-Guerin vaccine, given at birth against tuberculosis."
  },
  {
    "code" : "bopv",
    "display" : "Bivalent oral poliovirus vaccine",
    "definition" : "Live attenuated oral polio vaccine containing types 1 and 3. Given as a birth dose and at 6, 10 and 14 weeks."
  },
  {
    "code" : "ipv",
    "display" : "Inactivated poliovirus vaccine",
    "definition" : "Injectable inactivated polio vaccine, given at 14 weeks alongside the third bivalent oral dose. A distinct product from bOPV despite the register sharing one item code between them."
  },
  {
    "code" : "penta",
    "display" : "DTP-HepB-Hib (pentavalent) vaccine",
    "definition" : "Combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Given at 6, 10 and 14 weeks."
  },
  {
    "code" : "pcv10",
    "display" : "Pneumococcal conjugate vaccine (PCV10)",
    "definition" : "Ten-valent pneumococcal conjugate vaccine, given at 6, 10 and 14 weeks."
  },
  {
    "code" : "rota",
    "display" : "Rotavirus vaccine",
    "definition" : "Oral rotavirus vaccine, given at 6 and 10 weeks."
  },
  {
    "code" : "mr",
    "display" : "Measles-rubella vaccine",
    "definition" : "Combined measles and rubella vaccine. First dose at 9 months, second between 18 months and 2 years."
  },
  {
    "code" : "yf",
    "display" : "Yellow fever vaccine",
    "definition" : "Yellow fever vaccine, given at 9 months in yellow-fever-risk counties only, which is why it is excluded from the Fully Immunised Child milestone."
  }]
}